We are monitoring the impact of COVID-19 on Europe Cardiac Marker Testing Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4805
Share on
Share on

Europe Cardiac Marker Testing Market Research Report – Segmented By Type, Product, Disease, Testing & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends & Forecasts (2019 - 2024)

Pulished: February, 2020
ID: 4805
Pages: 145

Europe Cardiac Marker Testing Market Size & Growth (2019 – 2024):

The Size of the Europe Cardiac Marker Testing Market is anticipated to grow at 8.94% CAGR from 2019 to 2024 and it is expected that the market is valued at USD 0.71 billion in 2019 and is expected to reach USD 1.09 billion by 2024.

Cardiac marker tests identify blood chemicals associated with myocardial infarction (MI), commonly known as a heart attack. The myocardium is the middle layer of the heart wall composed of the heart muscle. Infarction is tissue death caused by an interruption in the blood supply to an area. Cardiac markers help physicians to assess acute coronary syndromes and to identify and manage high-risk patients. Creatine kinase-MB (CK-MB), myoglobin, homocysteine, C-reactive protein (CRP), troponin T (cTnT), and troponin I (cTnI) are all used for assessment of the suspected acute myocardial infarction. CK-MB, cTnT, and cTnI may also be used to identify and manage high-risk patients.

Factor such as an increase in the incidence and occurrences of cardiovascular diseases is among the main factors driving the market growth.  Furthermore, a number of factors such as growing instances of cardiovascular diseases, the rapidly increasing geriatric population, growing to fund from public-private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are driving the growth of the cardiac marker testing market. On the other hand, technical problems related to sample collection and storage and issues related to regulatory and reimburse schemes are expected to hinder the growth of the market.

Europe Cardiac Marker Testing Market has been segmented and sub-segmented into the following categories 

  • By Type: Troponin I & T, CK-MB, Myoglobin, BNP, hs-CRP
  • By Product: Reagent, Instrument (Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA))
  • By Disease: Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure
  • By Testing Lab, POC.
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe.

On the basis of region, Europe held the second-largest share of the market. Factors such as public-private initiatives to increase awareness related to early cardiac disease diagnosis in patients and physicians and increasing knowledge about technological advancements among lab professionals and cardiologists due to ongoing conferences and seminars are the key factors aiding the growth of the markets.

Prominent Companies leading the Europe Cardiac Marker Testing Market Profiled in the report are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS Roche Diagnostics Ltd., Abbott Laboratories, Siemens AG, Danaher Corporation, Alere Inc., bioMérieux SA, LSI Medience Corporation, Ortho Clinical Diagnostics, Randox Laboratories Ltd, and Guangzhou Wondfo Biotech Co. Ltd.

1.Introduction          

                1.1 Market Definition   

                1.2 Study Deliverables 

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions  

2. Research Methodology                   

                2.1 Introduction       

                2.2 Research Phases     

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview               

                3.1 Executive Summary  

                3.2 Key Inferences 

                3.3 Epidemiology      

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers  

                4.2 Market Restraints   

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

5. Market Segmentation                      

                5.1 Product

                                5.1.1 Introduction                                                           

                                5.1.2 Reagents and Kits                                                

                                5.1.3 Instruments                                                           

                                                5.1.3.1 Chemiluminescence                                        

                                                5.1.3.2 Immunofluorescence                                     

                                                5.1.3.3 Elisa                                        

                                                5.1.3.4 Immunochromatography                                              

                                5.1.4  Y-o-Y Growth Analysis, By Product                                                              

                                5.1.5  Market Attractiveness Analysis, By Product                                                            

                                5.1.6  Market Share Analysis, By Product                                                              

                5.2 Type      

                                5.2.1 Introduction                                                           

                                5.2.2 Troponin I & T                                                        

                                5.2.3 CK-MB                                                      

                                5.2.4 Myoglobin 

                                5.2.5 BNP                                                            

                                5.2.6 hsCRP                                                        

                                5.2.7 Y-o-Y Growth Analysis, By Type                                                     

                                5.2.8 Market Attractiveness Analysis, By Type                                                   

                                5.2.9 Market Share Analysis, By Type                                                     

                5.3 Disease       

                                5.3.1 Introduction                                                           

                                5.3.2 Acute Coronary Syndrome 

                                5.3.3 Myocardial Infarction                                                         

                                5.3.4 Congestive Heart Failure                                                   

                                5.3.5 Y-o-Y Growth Analysis, By Disease  

                                5.3.6  Market Attractiveness Analysis, By Disease                                                             

                                5.3.7  Market Share Analysis, By Disease                                                              

                5.4 Type of Testing

                                5.4.1 Introduction                                                           

                                5.4.2 Lab                                                             

                                5.4.3 Point-Of-Care Testing                                                        

                                5.4.4 Y-o-Y Growth Analysis, By Type of Testing 

                                5.4.5  Market Attractiveness Analysis, By Type of Testing                                                             

                                5.4.6  Market Share Analysis, By Type of Testing

6. Geographical Analysis                      

                6.1 Introduction       

                                6.1.1 Regional Trends                                                    

                                6.1.2 Impact Analysis                                                     

                                6.1.3 Y-o-Y Growth Analysis                                                        

                                                6.1.3.1 By Geographical Area                                     

                                                6.1.3.2 By Product                                           

                                                6.1.3.3 By Type                                 

                                                6.1.3.4 By Disease                                           

                                                6.1.3.5 By Type of Testing                                            

                                6.1.4  Market Attractiveness Analysis                                                     

                                                6.1.4.1 By Geographical Area                                     

                                                6.1.4.2 By Product                                           

                                                6.1.4.3 By Type                                 

                                                6.1.4.4 By Disease                                           

                                                6.1.4.5 By Type of Testing                                            

                                6.1.5  Market Share Analysis                                                      

                                                6.1.5.1 By Geographical Area                                     

                                                6.1.5.2 By Product                                           

                                                6.1.5.3 By Type                                 

                                                6.1.5.4 By Disease                                           

                                                6.1.5.5 By Type of Testing                                            

                6.2 U.K

                6.3 Spain     

                6.4 Germany    

                6.5 Italy       

                6.6 France  

               6.7 Rest of Europe

7.Strategic Analysis                

                7.1 PESTLE analysis 

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis      

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry                                                     

8.Market Leaders' Analysis                                                                                         

                8.1 Getinge Group  

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Financial analysis                                                  

                                8.1.4 Recent Developments                                                       

                                8.1.5 SWOT analysis                                                       

                                8.1.6 Analyst View                                                          

                8.2 Medtronic plc    

                8.3 LivaNova PLC     

                8.4 XENIOS Roche Diagnostics Ltd.   

                8.5 Abbott Laboratories 

                8.6 Siemens AG 

                8.7 Danaher Corporation     

                8.8 Alere Inc.    

                8.9 BioMérieux SA  

9.Competitive Landscape                     

                9.1 Market share analysis     

                9.2 Merger and Acquisition Analysis

                9.3 Agreements, Collaborations, and Joint Ventures  

                9.4 New Product Launches  

10.Market Outlook and Investment Opportunities                   

Appendix                    

                a) List of Tables                

                b) List of Figures    

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of Type, Product, Disease and Testing along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the Europe Market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensivePESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Cardiac Marker Testing  Market By Type, From 2019-2024 ( USD Billion )
  2. Europe Troponin I & T Market By Region, From 2019-2024 ( USD Billion )
  3. Europe Insulin Delivery Market By Region, From 2019-2024 ( USD Billion )
  4. Europe CK-MB Market By Region, From 2019-2024 ( USD Billion )
  5. Europe Myoglobin Market By Region, From 2019-2024 ( USD Billion )
  6. Europe BNP Market By Region, From 2019-2024 ( USD Billion )
  7. Europe hsCRP Market By Region, From 2019-2024 ( USD Billion )
  8. Europe Cardiac Marker Testing  Market By Product, From 2019-2024 ( USD Billion )
  9. Europe Reagent Market By Region, From 2019-2024 ( USD Billion )
  10. Europe Instrument Market By Region, From 2019-2024 ( USD Billion )
  11. Europe Chemiluminescence Market By Region, From 2019-2024 ( USD Billion )
  12. Europe Immunofluorescence Market By Region, From 2019-2024 ( USD Billion )
  13. Europe Immunochromatography Market By Region, From 2019-2024 ( USD Billion )
  14. Europe ELISA Market By Region, From 2019-2024 ( USD Billion )
  15. Europe Cardiac Marker Testing  Market By Disease, From 2019-2024 ( USD Billion )
  16. Europe Acute Coronary Syndrome Market By Region, From 2019-2024 ( USD Billion )
  17. Europe Myocardial Infarction Market By Region, From 2019-2024 ( USD Billion )
  18. Europe Congestive Heart Failure Market By Region, From 2019-2024 ( USD Billion )
  19. Europe Cardiac Marker Testing  Market By Testing, From 2019-2024 ( USD Billion )
  20. Europe Lab Market By Region, From 2019-2024 ( USD Billion )
  21. Europe POC  Market By Region, From 2019-2024 ( USD Billion )
  22. U.K. Cardiac Marker Testing  Market By Type, From 2019-2024 ( USD Billion )
  23. U.K. Cardiac Marker Testing  Market By Product, From 2019-2024 ( USD Billion )
  24. U.K. Cardiac Marker Testing  Market By Disease, From 2019-2024 ( USD Billion )
  25. U.K. Cardiac Marker Testing  Market By Testing, From 2019-2024 ( USD Billion )
  26. Germany Cardiac Marker Testing  Market By Type, From 2019-2024 ( USD Billion )
  27. Germany Cardiac Marker Testing  Market By Product, From 2019-2024 ( USD Billion )
  28. Germany Cardiac Marker Testing  Market By Disease, From 2019-2024 ( USD Billion )
  29. Germany Cardiac Marker Testing  Market By Testing, From 2019-2024 ( USD Billion )
  30. France Cardiac Marker Testing  Market By Type, From 2019-2024 ( USD Billion )
  31. France Cardiac Marker Testing  Market By Product, From 2019-2024 ( USD Billion )
  32. France Cardiac Marker Testing  Market By Disease, From 2019-2024 ( USD Billion )
  33. France Cardiac Marker Testing  Market By Testing, From 2019-2024 ( USD Billion )
  34. Italy Cardiac Marker Testing  Market By Type, From 2019-2024 ( USD Billion )
  35. Italy Cardiac Marker Testing  Market By Product, From 2019-2024 ( USD Billion )
  36. Italy Cardiac Marker Testing  Market By Disease, From 2019-2024 ( USD Billion )
  37. Italy Cardiac Marker Testing  Market By Testing, From 2019-2024 ( USD Billion )
  38. Spain Cardiac Marker Testing  Market By Type, From 2019-2024 ( USD Billion )
  39. Spain Cardiac Marker Testing  Market By Product, From 2019-2024 ( USD Billion )
  40. Spain Cardiac Marker Testing  Market By Disease, From 2019-2024 ( USD Billion )
  41. Spain Cardiac Marker Testing  Market By Testing, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample